Spanish Biotech Telum Therapeutics Raises 18 Million Euros in Series A for Antimicrobial Therapy Development
Telum Therapeutics, a biotech company leveraging metagenomic datasets, synthetic biology, and generative AI to develop novel antimicrobial therapies, announced the closure of an 18 million euro Series A round. The funding will advance its primary program for hospital-acquired bacterial pneumonia.